ADYNOVI

recombinant antihemophilic factor VIII Fc fusion protein · Shire

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for ADYNOVI, covering 2024-06-17 to 2026-07-09. Get the full timeline:

Most recent: EMA Authorised: Adynovi (rurioctocog alfa pegol) — Baxalta Innovations GmbH